Keymed Biosciences Co.ltd

This study follows patients with atopic dermatitis (eczema) who previously participated in CM512 trials to see how safe and effective the treatment remains over the long term. Researchers will track side effects and how well the treatment continues to control eczema symptoms. The…

This study is testing an experimental drug called CM336 in adults whose primary light-chain amyloidosis has returned or hasn't responded to previous treatments. The trial aims to see if CM336 can help control the disease by measuring blood response rates and checking safety. Abou…

This study is testing a new drug called CM518D1 in people with advanced solid tumors that have spread. Researchers want to find the safest dose and see if the drug helps shrink tumors. The trial will enroll 434 adults to check for side effects and measure how well the treatment w…

This early-stage study is testing an experimental drug called CM336 in adults whose autoimmune blood disorders have not responded to other treatments. The main goals are to see if the drug is safe and if it can help improve patients' blood cell counts. Researchers will monitor fo…

This is the first study in people for a new drug called CM383. It will test how the body processes the drug and check for side effects in 30 healthy men. The drug will be given as a single dose, either through an IV or an injection under the skin.

This is an early safety study testing a new drug called CM559 in healthy male volunteers. Researchers will give different doses to 40 participants to check for side effects and see how the body processes the drug. The main goal is to determine if the drug is safe enough for furth…